Abu dhabi: NYU Abu Dhabi and RTW Investments, LP ('RTW') have announced a strategic collaboration aimed at advancing executive education, thought leadership, and cross-sector engagement in healthcare, biotechnology, and life sciences across the region.
According to Emirates News Agency, the collaboration combines RTW's global investment expertise in biopharma and medical technologies with NYUAD Executive Education's academic platform and faculty leadership. This partnership will bring together investors, policymakers, and industry leaders to discuss the future of healthcare systems, investing, and innovation.
As part of the initiative, NYUAD and RTW plan to co-develop a flagship Healthcare Event and executive education program, scheduled for late 2026. This will include a series of executive-level offerings tailored for sovereign wealth funds, major institutions, and policymakers. The initiative aims to foster informed dialogue on healthcare investing, innovation, emerging technologies, and policy alignment, supporting knowledge exchange across the GCC.
Chief Operating Officer of NYU Abu Dhabi Amol Dani expressed satisfaction with the partnership, highlighting RTW's deep experience in biotechnology and healthcare. The collaboration aims to deliver programs that help senior leaders better understand emerging developments in the sector and respond to complex global health challenges.
The partnership will allow NYUAD to expand its executive education portfolio in areas aligned with Abu Dhabi's strategic priorities, focusing on innovation-driven economic diversification and knowledge development in high-growth sectors.
Roderick Wong, MD, Managing Partner and Chief Investment Officer at RTW Investments, emphasized the importance of sound policy, informed leadership, and sustained investment for healthcare innovation. He noted that the collaboration with NYU Abu Dhabi will cultivate a new cadre of leaders capable of translating breakthrough science into resilient medical advances.
The collaboration builds upon a longstanding relationship between NYU and RTW and underscores the organizations' shared commitment to advancing medical innovation globally.
Woody Stileman, Managing Director of Business Development at RTW Investments, who leads RTW's efforts in the Middle East, remarked on the Middle East's emergence as a significant center for healthcare investment and innovation. He stated that the partnership with NYU Abu Dhabi signifies a commitment to supporting the region's investment appetite and innovative thinking, which aims to build a robust ecosystem connecting global capital, scientific talent, and policy frameworks to improve long-term health outcomes.